Sanofi reports 1.21 billion shares outstanding as of June 30, 2026

Sanofi said it had 1,214,099,027 issued shares outstanding as of June 30, 2026.

The company reported 1,333,528,431 real voting rights, excluding treasury shares, and 1,349,556,948 theoretical voting rights, including treasury shares.